KMTS - NASDAQ
Kestra Medical Technologies, Ltd.
$18.82
-6.8%Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
At a Glance
Live Snapshotkmts
Total Non-Current Assets
Last Annual Value
40.42M
3-Year CAGR
111%
5-Year CAGR
88%
10-Year CAGR
37%
Kestra Medical Technologies, Ltd. Competitors Analysis of Total Non-Current Assets
| Company | Total Non-Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 Kestra Medical Technologies, Ltd. NASDAQ:KMTS | 40.42M | 25.9% | 56.3% | N/A | |
 Azenta, Inc. NASDAQ:AZTA | 1.35B | -2.7% | 5.3% | 13.3% | |
 Pulse Biosciences, Inc. NASDAQ:PLSE | 12.69M | -2.8% | -6.3% | 2.8% | |
 BioLife Solutions, Inc. NASDAQ:BLFS | 285.71M | -0.7% | -7.7% | 56.2% | |
 Neogen Corporation NASDAQ:NEOG | 2.87B | -10.3% | 54.2% | 30.4% | |
 NovoCure Limited NASDAQ:NVCR | 157.59M | 12.2% | 19.0% | 22.8% | |
 Precigen, Inc. NASDAQ:PGEN | 41.39M | -20.5% | -27.3% | -23.9% | |
 Terns Pharmaceuticals, Inc. NASDAQ:TERN | 884.00K | -6.6% | -5.0% | N/A | |
 STAAR Surgical Company NASDAQ:STAA | 150.07M | 6.7% | 15.1% | 25.5% |
Kestra Medical Technologies, Ltd. Fair Value Envelope
Related Guides
Continue your KMTS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.